|
Publication: time to inclusion of medicines in National Essential Medicines Lists compared to the WHO Model List
|
|
0
|
23
|
November 6, 2025
|
|
Publication: Assessing the Impact of Antimicrobial Resistance Awareness Interventions Among Schoolchildren in Bangladesh
|
|
0
|
29
|
October 19, 2025
|
|
Contextual constraints and dilemmas influencing health providers’ prescription practices in a conflict-affected area
|
|
0
|
32
|
October 18, 2025
|
|
Publication: Human Antimicrobial Use in Bangladesh: Five-Year Trend Analysis Including COVID-19 Pandemic Era
|
|
0
|
15
|
October 16, 2025
|
|
Publication: Access to Medical Products in the WHO South-East Asia Region 2025
|
|
0
|
32
|
October 15, 2025
|
|
WHO releases new reports on new tests and treatments in development for bacterial infections
|
|
0
|
29
|
October 13, 2025
|
|
generic risdiplam for SMA in India
|
|
0
|
11
|
October 10, 2025
|
|
First lenacapavirs prequalified
|
|
0
|
36
|
October 10, 2025
|
|
Pharma shift away from infectious disease could spell disaster for the world poorest people
|
|
0
|
23
|
October 10, 2025
|
|
Assessing the performance of local pharmaceutical systems: An analytical approach to improve access to medicine
|
|
0
|
31
|
October 5, 2025
|
|
Country preparedness for the introduction and appropriate use of antibiotics: operational guidance
|
|
0
|
37
|
October 3, 2025
|
|
List of National Regulatory Authorities (NRAs) operating at maturity level 3 (ML3) and maturity level 4 (ML4)
|
|
0
|
36
|
October 3, 2025
|
|
Country preparedness for the introduction and appropriate use of antibiotics: operational guidance
|
|
0
|
40
|
October 3, 2025
|
|
Availability of essential medicines in 14 remaining health facilities in Gaza
|
|
0
|
52
|
October 1, 2025
|
|
WHO Global Forum for Public Procurement of Health Products
|
|
0
|
43
|
September 20, 2025
|
|
Dispensing of medicines for asthma and COPD through the government health insurance in Syria
|
|
0
|
62
|
September 13, 2025
|
|
Can AI transform pharmaceutical services in LMICs — or will it create more risks than solutions?
|
|
0
|
97
|
September 9, 2025
|
|
WHO updates list of essential medicines to include key cancer, diabetes treatments
|
|
0
|
44
|
September 5, 2025
|
|
Upcoming Event: The PtD Supply Chain Workforce Summit – From Coalition to Network
|
|
0
|
50
|
September 9, 2025
|
|
Introducing WHO e-Learning course on pharmaceutical pricing policies
|
|
0
|
46
|
September 5, 2025
|
|
Public Alert No. 027/2025 – Alert on Confirmed Counterfeit Postinor2 (Levonorgestrel 0.75mg) in Nigeria
|
|
0
|
40
|
September 2, 2025
|
|
Diethylene glycol (DEG) and ethylene glycol (EG) contamination of paediatric medicines
|
|
0
|
25
|
August 14, 2025
|
|
Vacancy: PV Manager UWC, South Africa
|
|
0
|
24
|
July 31, 2025
|
|
Department of regulation and prequalification, Strategic Action Plan 2025-2028
|
|
0
|
27
|
July 31, 2025
|
|
WHO and UNODC release landmark report on contaminated medicines, urging action to protect patients from preventable harm
|
|
0
|
70
|
July 25, 2025
|
|
new WHO Essential Medicines roadmap 2025-2030
|
|
0
|
43
|
July 22, 2025
|
|
Hiring 2 roles in global health policy and advocacy at MSF-USA
|
|
0
|
26
|
July 21, 2025
|
|
WHO Global Forum for Public Procurement of Health Products
|
|
0
|
32
|
July 18, 2025
|
|
Lenacapavir could cost just $25/year: new analysis calls for urgent action
|
|
0
|
13
|
July 17, 2025
|
|
Factsheet on key considerations for inter-country pooled procurement of health products
|
|
0
|
38
|
July 15, 2025
|